Evolving towards a human-cell based and multiscale approach to drug discovery for CNS disorders
A disruptive approach to therapeutic discovery and development is required in order to significantly improve the success rate of drug discovery for central nervous system (CNS) disorders. In this review, we first assess the key factors contributing to the frequent clinical failures for novel drugs....
Main Authors: | Eric eSchadt, Sean eBuchanan, Kristen eBrennand, Kalpana eMerchant |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00252/full |
Similar Items
-
Epigenetic assays for chemical biology and drug discovery
by: Sheraz Gul
Published: (2017-04-01) -
Production of single- and multiple-gene-modified mice via maternal SpCas9-based gene editing
by: Takayuki Sakurai, et al.
Published: (2021-06-01) -
Editorial: Integration of structural biology data in lead drug discovery and optimization
by: Pietro Roversi, et al.
Published: (2023-02-01) -
Application of Fragment-Based Drug Discovery to Versatile Targets
by: Qingxin Li
Published: (2020-08-01) -
Protocol for mapping double-stranded DNA break sites across the genome with translocation capture sequencing
by: Joe R. Delaney, et al.
Published: (2023-06-01)